Micro-RNA: The darkhorse of cancer
The discovery of micro RNAs (miRNA) in cancer has opened up new vistas for researchers
in recent years. Micro RNAs area set of small, endogenous, highly conserved, non-coding …
in recent years. Micro RNAs area set of small, endogenous, highly conserved, non-coding …
MicroRNAs as cancer players: potential clinical and biological effects
E Bandres, X Agirre, N Ramirez, R Zarate… - DNA and cell …, 2007 - liebertpub.com
MicroRNAs (miRNAs) are nonprotein-coding RNAs that function as posttranscriptional gene
regulators. They can regulate their targets directly by mRNA cleavage or by repressing their …
regulators. They can regulate their targets directly by mRNA cleavage or by repressing their …
MicroRNAs in endometrial cancer
MicroRNAs (miRNAs) are small non-coding ribonucleic acids (RNAs) of approximately 22
bp that induce RNA interference with a complementary messenger RNA (mRNA) and act in …
bp that induce RNA interference with a complementary messenger RNA (mRNA) and act in …
MicroRNAs and cancer: current state and future perspectives in urologic oncology
A Schaefer, M Jung, G Kristiansen, M Lein… - … Oncology: Seminars and …, 2010 - Elsevier
MicroRNAs (miRNAs) are small non-protein coding RNAs that regulate basic cellular
processes and are associated with cancer characteristics. It is the aim of this review to …
processes and are associated with cancer characteristics. It is the aim of this review to …
MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
N Yang, S Kaur, S Volinia, J Greshock, H Lassus… - Cancer research, 2008 - AACR
Abstract MicroRNAs (miRNA) are approximately 22-nucleotide noncoding RNAs that
negatively regulate protein-coding gene expression in a sequence-specific manner via …
negatively regulate protein-coding gene expression in a sequence-specific manner via …
Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer
ML Gasparri, A Casorelli, E Bardhi… - Tumor …, 2017 - journals.sagepub.com
Breast cancer is the most common malignancy in women worldwide, and ovarian cancer is
the most lethal gynecological malignancy. Women carrying a BRCA1/2 mutation have a very …
the most lethal gynecological malignancy. Women carrying a BRCA1/2 mutation have a very …
[HTML][HTML] miR‑148a‑3p suppresses epithelial ovarian cancer progression primarily by targeting c‑Met
W Wang, J Dong, M Wang, S Yao… - Oncology …, 2018 - spandidos-publications.com
MicroRNAs (miRNAs) are a group of small non‑coding RNAs that modulate post‑
transcriptional gene expression. It has been demonstrated that various miRNAs may be …
transcriptional gene expression. It has been demonstrated that various miRNAs may be …
MicroRNAs and target molecules in bladder cancer
PK Parizi, F Yarahmadi, HM Tabar, Z Hosseini, A Sarli… - Medical Oncology, 2020 - Springer
Bladder cancer (BC) is considered as one of the most common malignant tumors in humans
with complex pathogenesis including gene expression variation, protein degradation, and …
with complex pathogenesis including gene expression variation, protein degradation, and …
[HTML][HTML] MicroRNAs: Recent insights towards their role in male infertility and reproductive cancers
Spermatogenesis is a tightly controlled, multi-step process in which mature spermatozoa are
produced. Disruption of regulatory mechanisms in spermatogenesis can lead to male …
produced. Disruption of regulatory mechanisms in spermatogenesis can lead to male …